---
title: "AGS: Net profit in the third quarter was 50.9893 million yuan, a year-on-year decrease of 30.15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262883591.md"
description: "AGS announced that its revenue for the third quarter was 157 million yuan, a year-on-year decrease of 3.89%; net profit was 50.9893 million yuan, a year-on-year decrease of 30.15%. Revenue for the first three quarters was 459 million yuan, a year-on-year increase of 7.51%; net profit was 177 million yuan, a year-on-year decrease of 10.35%"
datetime: "2025-10-27T11:33:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262883591.md)
  - [en](https://longbridge.com/en/news/262883591.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262883591.md)
generator: "portal-rs"
---

# AGS: Net profit in the third quarter was 50.9893 million yuan, a year-on-year decrease of 30.15%

AGS announced that its revenue for the third quarter was 157 million yuan, a year-on-year decrease of 3.89%; net profit was 50.9893 million yuan, a year-on-year decrease of 30.15%. Revenue for the first three quarters was 459 million yuan, a year-on-year increase of 7.51%; net profit was 177 million yuan, a year-on-year decrease of 10.35%

### Related Stocks

- [688581.CN](https://longbridge.com/en/quote/688581.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Movida releases 2Q26 institutional presentation factsheet](https://longbridge.com/en/news/296495308.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [Navigator invests about EUR 115 million in new tissue paper machine at Aveiro complex](https://longbridge.com/en/news/296775961.md)
- [Bizlink Holding Has Detected Parts Of Its Data Systems Have Been Compromised By Internet Security Incident](https://longbridge.com/en/news/296750112.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**